Nephropathic Infantile Cystinosis
Description
Nephropathic infantile cystinosis is the most common and severe form of cystinosis (see this term), a metabolic disease characterized by an accumulation of cystine inside the lysosomes that causes damage in different organs and tissues, particularly in the kidneys and eyes.
Clinical Features
Top most frequent phenotypes and symptoms related to Nephropathic Infantile Cystinosis
- Growth delay
- Failure to thrive
- Cognitive impairment
- Vomiting
- Constipation
- Acidosis
- Photophobia
- Abnormality of the cerebral white matter
- Pigmentary retinopathy
- Dehydration
And another 17 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Doctors, researchs, and experts related to Nephropathic Infantile Cystinosis extracted from public data.
Nephropathic Infantile Cystinosis Experts map
Current Researchs and researchers
-
Coordinator of expert centre - Responsible for diagnostic tests - Principal investigator of clinical trial - Investigator of research project - Coordinator of research network - Director of laboratoryROMA — Dr Francesco EMMA
-
Institution/s:
— Dipartimento di Nefrologia e Urologia, IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO -
Research area/topic::
NTC study: Novel Therapies for Cystinosis - IT
-
Institution/s:
Nephropathic Infantile Cystinosis Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)
View the complete list with 129 more genes
Specificity
1 %
Genes
100 % |
![]() By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
SGSH, SLC17A5, SMPD1, TCF4, MCOLN1, NPC2, ADAMTSL2, DNAJC5, SUMF1, TPP1, CLN3, CLN5, CLN6, CLN8, DYM, ANTXR2, COL11A2, PEX26, GNE, CTNS , (...)
View the complete list with 54 more genes
Specificity
2 %
Genes
100 % |
![]() By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
CTNS
Specificity
100 %
Genes
100 % |
![]() By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina).
SGSH, SLC17A5, SMPD1, MCOLN1, NPC2, DNAJC5, SUMF1, TPP1, CLN3, CLN5, CLN6, CLN8, GNPTG, CTNS, CTSD, CTSK, HGSNAT, MFSD8, GNPTAB, AGA , (...)
View the complete list with 30 more genes
Specificity
2 %
Genes
100 % |
![]() By Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine (United States).
SCNN1A, SCNN1B, SLC12A1, SLC12A3, SLC2A2, VDR, WNK4, CASR, BSND, CDC73, SLC22A12, CLCN5, CLCNKB, SLC34A3, CLDN16, CLDN19, FAM20C, FAM20A, HOGA1, CTNS , (...)
View the complete list with 28 more genes
Specificity
3 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
CTNS
Specificity
100 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
CTNS
Specificity
100 %
Genes
100 % |
You can get up to 42 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like LEGG-CALVE-PERTHES DISEASE; LCPD GLYCOGEN STORAGE DISEASE XII; GSD12 LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD EPISODIC ATAXIA TYPE 1 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A